Skip to main content
. 2006 Mar 26;6:81. doi: 10.1186/1471-2407-6-81

Figure 1.

Figure 1

Observed changes in CA 15-3 levels in patients with stable disease ≥ 6 months from baseline to 6th treatment (n = 28).